FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
Wang S, Xiao Z, Hong Z, Jiao H, Zhu S, Zhao Y, Bi J, Qiu J, Zhang D, Yan J, Zhang L, Huang C, Li T, Liang L, Liao W, Ye Y, Ding Y.
Wang S, et al. Among authors: li t.
Cancer Lett. 2018 Dec 28;439:78-90. doi: 10.1016/j.canlet.2018.09.026. Epub 2018 Sep 22.
Cancer Lett. 2018.
PMID: 30253191